Zdrowie i gospodarka · 19/11/1997

FDA Approves Ventritex, Inc.'s TVL Lead System for Premarket Approval

The US Food and Drug Administration (FDA) has granted premarket approval to Ventritex, Inc.'s TVL Lead System, following an application submitted by the company, in accordance with the Federal Food, Drug, and Cosmetic Act (FDCA). The approval was notified to Ventritex, Inc. by the FDA's Center for Devices and Radiological Health (CDRH) on May 10, 1996.